Evidence map›Paper›PMID 31653462›Full record

ArticleJournal of pediatric urology2019

Urodynamic and imaging findings in infants with myelomeningocele may predict need for future augmentation cystoplasty.

Lauren E Corona, Ted Lee, Kathryn Marchetti, Courtney S Streur, Vesna Ivancic, Kate H Kraft, David A Bloom, Julian Wan, John M Park

Open access · greenAbstract read
In one paragraph

Article in Journal of pediatric urology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Lauren E CoronaUniversity of Michigan, Department of Urology, 1500 E Medical Center Drive, SPC 5330, Ann Arbor, MI, USA. Electronic address: lcorona@med.umich.edu.
Ted LeeUniversity of Michigan, Department of Urology, 1500 E Medical Center Drive, SPC 5330, Ann Arbor, MI, USA.
Kathryn MarchettiUniversity of Michigan, Department of Urology, 1500 E Medical Center Drive, SPC 5330, Ann Arbor, MI, USA.
Courtney S StreurUniversity of Michigan, Department of Urology, 1500 E Medical Center Drive, SPC 5330, Ann Arbor, MI, USA.
Vesna IvancicUniversity of Michigan, Department of Urology, 1500 E Medical Center Drive, SPC 5330, Ann Arbor, MI, USA.
Kate H KraftUniversity of Michigan, Department of Urology, 1500 E Medical Center Drive, SPC 5330, Ann Arbor, MI, USA.
David A BloomUniversity of Michigan, Department of Urology, 1500 E Medical Center Drive, SPC 5330, Ann Arbor, MI, USA.
Julian WanUniversity of Michigan, Department of Urology, 1500 E Medical Center Drive, SPC 5330, Ann Arbor, MI, USA.
John M ParkUniversity of Michigan, Department of Urology, 1500 E Medical Center Drive, SPC 5330, Ann Arbor, MI, USA.
University of Michigan · US

Funding

University of Michigan UroEPI Career Development ProgramK12DK111011 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CLEMENS, J. QUENTIN, SARMA, ARUNA V · 2016 to 2025
$3.6M
NIDDK NIH HHS K12 DK111011
6 · The paper itself

Abstract

introductionUrologic issues are persistent and important causes of morbidity and mortality in patients with myelomeningocele. Classically, patients with elevated bladder pressures despite adherence to clean intermittent catheterization (CIC) and pharmacotherapy undergo augmentation cystoplasty (AC). Currently, there is little understanding of which infants are more likely to require AC later.

objectiveIn this context, the authors studied whether unfavorable urodynamic or imaging findings in patients with myelomeningocele during infancy could predict future AC. The authors hypothesized that infants born with elevated bladder pressures, vesicoureteral reflux (VUR), and/or hydronephrosis would be more likely to undergo AC. STUDY

designThe authors retrospectively identified patients with myelomeningocele at their institution who were followed-up since infancy (<1 year of age), with a minimum of eight continuous years of follow-up. Standard care protocol included cystometrogram, voiding cystourethrogram (VCUG), and renal ultrasound during infancy. The primary outcome was AC for elevated bladder pressures despite attempts at more conservative management with medical therapy and CIC. Specifically, the authors evaluated for differences in augmentation rates based on gender, level of lesion, presence of detrusor leak point pressure (DLPP) or end-fill pressure (EFP) greater than 40 cm H

resultsA total of 97 patients met the inclusion criteria. The median follow-up time was 13.8 years. Augmentation cystoplasty was performed for 17 patients (17.5%) at a median age of 114 months (9.5 years). Detrusor leak point pressure/EFP was greater than 40 cm H DISCUSSION: Infants with myelomeningocele and elevated bladder pressures and VUR should be closely monitored by urodynamic testing and imaging studies. Parents can be counseled regarding the potentially higher risk for future AC in these patients. Nonetheless, the majority of high-risk infants will safely avoid AC with conservative management.

Indexed as

ForecastingChildChild, PreschoolFemaleFollow-Up StudiesHumansInfantMaleMeningomyelocelePlastic Surgery ProceduresPredictive Value of TestsRetrospective StudiesRisk FactorsUltrasonographyUrinary BladderUrinary Bladder, NeurogenicAugmentation cystoplastyDetrusor leak point pressureMyelomeningoceleVesicoureteral reflux

Identifiers

PMID31653462
PMCPMC7086486
OpenAlexW2974650083

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.